Diagnosis of severe Chlamydia psittaci pneumonia by metagenomic next-generation sequencing: 2 case reports

Chunhua Luo1, Yanping Lin1,2, Chengwen Chen1

  • 1Department of Intensive Care Unit, The Second Affiliated Hospital of Fujian Medical University, 950 Donghai Street, Fengze District, Quanzhou City, Fujian Province, China.

Insights

Psittacosis, a severe pneumonia caused by Chlamydia psittaci, can be effectively diagnosed using Metagenomic next-generation sequencing (MNGS). Early MNGS identification and doxycycline treatment improved patient outcomes in two severe cases.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Genomics

Background:

  • Psittacosis, caused by Chlamydia psittaci (C. psittaci), is an infectious disease that manifests as pneumonia in humans.
  • Diagnosing psittacosis can be challenging, necessitating advanced diagnostic techniques for timely and accurate identification.

Observation:

  • This study documents two severe cases of C. psittaci pneumonia in patients admitted to the Intensive Care Unit.
  • Metagenomic next-generation sequencing (MNGS) was employed to analyze bronchoalveolar lavage fluid from both patients.

Findings:

  • MNGS successfully detected C. psittaci nucleic acid sequences in both severe pneumonia cases.
  • Treatment with doxycycline was administered and proved effective in managing the infection.

Implications:

  • Metagenomic next-generation sequencing (MNGS) facilitates early pathogen identification, significantly shortening diagnosis and treatment timelines.
  • The implementation of MNGS can lead to improved patient prognosis in cases of severe psittacosis pneumonia.

Related Concept Videos